As much as 50 to 75 percent of obesity has genetic influences. Just what those genetic influences are that affect body weight have not been identified. Obese people should be evaluated for medical consequences of their obesity. Motivated persons are encourage to enter medically supervised treatment programs that use a multidisciplinary approach to weight loss. Many people are tempted by ads that use celebrities to tout liquid fasting diets for weight loss. Ads claim quick and easy weight loss with use of such products. Very obese patients may be referred to these types of diets. Their diets are carefully supervised by their healthcare provider. Fasting diets for weight loss may be right for obese persons who have serious weight-related medical problems. Rapid weight loss is the primary advantage of using these diets. This may be helpful in motivating the individual to continue with the program. This may help to support lifestyle changes which are needed for continued weight loss. Binge eating can be triggered by many things such as stress, depression, loneliness or anger. Food is used as a way of dealing with issues other than hunger. Binge eating is like bulimia, but does not include purging behaviors. A diagnosis of binge-eating disorder is made when a person binges an average of two days per week over a six month period. The following guidelines have been developed that may help control binge eating:
- Eat only at established meal times.
- Avoid keeping foods around that may trigger bingeing.
- Avoid fad or very restrictive diets.
- Keep a food diary and log to assess what prompted the binge.
Many people may actually be overfat but not overweight. Fat can also be hidden throughout the body. A person may be overfat without the appearance of being overweight. As we age, muscle tissue is replaced with fat. This occurs despite regular exercise. Studies show that a 20 percent increase in body weight increases the risk for heart disease, high blood pressure and diabetes. The risk of developing weight associated medical problems increases if the majority of body fat is located in the abdominal area. This risk decreases if body fat is primarily located in the hips, buttock and thigh region.
The most recent drug in the fight against obesity is Xenical. A new class of non-systemic anti-obesity drug called lipase inhibitors which act in the gastrointestinal tract to prevent the absorption of fat by about 30 percent. Drugs in this class do not achieve their effect through brain chemistry or central nervous system stimulation. In other words, Xenical is not an appetite suppressant or metabolic inducer. Brand names of the most effective prescription diet medications on the market today are: Phentermine, Adipex-P, Fastin, Ionamin, Bontril, Plegine, Tenuate, Xenical. Most studies of appetite suppressant medications show that a patient's weight tends to level off after four to six months while still on medication treatment. While some patients and physicians may be concerned that this shows tolerance to the medications, the leveling off may mean that the medication has reached its limit of effectiveness. Based on the currently available studies, it is not clear if weight gain with continuing treatment is due to drug tolerance. Obesity often is viewed as the result of a lack of willpower, weakness, or a lifestyle "choice" - the choice to overeat and under exercise. The belief that persons choose to be obese adds to the hesitation of health professionals and patients to accept the use of long-term appetite suppressant medication treatment to manage obesity. Appetite suppressant medications are not "magic bullets", or a one- shot fix. They cannot take the place of improving one's diet and becoming more physically active. The major role of medications appears to be to help a person stay on a diet and exercise plan to keep off the weight they lose.
![Being overweight increases your risk of health conditions. Weight loss.](img/weight_loss_67.jpg)
Terms interpretationFDA
- Food and Drug Administration: A government agency that oversees public safety in relation to drugs and medical devices. The FDA gives approval to pharmaceutical companies for commercial marketing of their products.
Fat blocker
- Drugs that block the absorption of fat or calories, and lose substantial weight.
Overweight
- Weighing more than is normal, necessary, or allowed, especially having more body weight than is considered normal or healthy for one's age or build.
Appetite
- An instinctive physical desire, especially one for food or drink. Decreased desire to eat is termed anorexia, while polyphagia (or "hyperphagia") is increased eating. Disregulation of appetite contributes to anorexia nervosa and cachexia, or oppositely, overeating.
Diabetes
- Any of several metabolic disorders marked by excessive discharge of urine and persistent thirst, especially one of the two types of diabetes mellitus.
Diet
- A regulated selection of foods, as for medical reasons or cosmetic weight loss.
- A solutions designed to reduce or suppress the appetite.
Fat
- Any of various soft, solid, or semisolid organic compounds constituting the esters of glycerol and fatty acids and their associated organic groups.
Obesity
- The condition of being obese; increased body weight caused by excessive accumulation of fat.
Stress
- A state of extreme difficulty, pressure, or strain.
- A physical and psychological response that results from being exposed to a demand or pressure.
Suppress
- To curtail or prohibit the activities of.
- To inhibit the expression of (an impulse, for example).
- To bring to an end forcibly as if by imposing a heavy weight.
|